OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design and Development of Cholinesterase Dual Inhibitors towards Alzheimer's Disease Treatment: A Focus on Recent Contributions from Computational and Theoretical Perspective
Fatima Y. Adeowo, Monsurat M. Lawal, Hezekiel M. Kumalo
ChemistrySelect (2020) Vol. 5, Iss. 44, pp. 14136-14152
Closed Access | Times Cited: 6
Fatima Y. Adeowo, Monsurat M. Lawal, Hezekiel M. Kumalo
ChemistrySelect (2020) Vol. 5, Iss. 44, pp. 14136-14152
Closed Access | Times Cited: 6
Showing 6 citing articles:
Enhancing the Therapeutic Effect in Alzheimer's Disease Drugs: The role of Polypharmacology and Cholinesterase inhibitors
M. Margarida Martins, Paula S. Branco, Luı́sa M. Ferreira
ChemistrySelect (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 18
M. Margarida Martins, Paula S. Branco, Luı́sa M. Ferreira
ChemistrySelect (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 18
The anti-Alzheimer potential of novel spiroindolin-1,2-diazepine derivatives as targeted cholinesterase inhibitors with modified substituents
Hormoz Pourtaher, Alireza Hasaninejad, Shahrokh Zare, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Hormoz Pourtaher, Alireza Hasaninejad, Shahrokh Zare, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Alzheimer's Disease and β-secretase Inhibition: An Update with a Focus on Computer-aided Inhibitor Design
Samuel Chima Ugbaja, Isiaka A. Lawal, Hezekiel M. Kumalo, et al.
Current Drug Targets (2021) Vol. 23, Iss. 3, pp. 266-285
Closed Access | Times Cited: 17
Samuel Chima Ugbaja, Isiaka A. Lawal, Hezekiel M. Kumalo, et al.
Current Drug Targets (2021) Vol. 23, Iss. 3, pp. 266-285
Closed Access | Times Cited: 17
Pharmacophore mapping of the crucial mediators of acetylcholinesterase and butyrylcholinesterase dual inhibition in Alzheimer's disease
Fatima Y. Adeowo, Ahmed A. El‐Rashedy, Murtala A. Ejalonibu, et al.
Molecular Diversity (2022) Vol. 26, Iss. 5, pp. 2761-2774
Closed Access | Times Cited: 7
Fatima Y. Adeowo, Ahmed A. El‐Rashedy, Murtala A. Ejalonibu, et al.
Molecular Diversity (2022) Vol. 26, Iss. 5, pp. 2761-2774
Closed Access | Times Cited: 7
Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment
Fatima Y. Adeowo, Tosin Philip Oyetunji, Murtala A. Ejalonibu, et al.
Chemistry & Biodiversity (2021) Vol. 18, Iss. 11
Closed Access | Times Cited: 7
Fatima Y. Adeowo, Tosin Philip Oyetunji, Murtala A. Ejalonibu, et al.
Chemistry & Biodiversity (2021) Vol. 18, Iss. 11
Closed Access | Times Cited: 7
African Jointfir (Gnetum africanum) and Editan (Lasianthera africana) leaf alkaloid extracts exert antioxidant and anticholinesterase activities in fruit fly (Drosophila melanogaster)
Ganiyu Oboh, Ayomide Victor Atoki, Adedayo O. Ademiluyi, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 6, pp. 2708-2718
Open Access | Times Cited: 2
Ganiyu Oboh, Ayomide Victor Atoki, Adedayo O. Ademiluyi, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 6, pp. 2708-2718
Open Access | Times Cited: 2
